Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death

Kuroki, Lindsay

332
Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death

Saturday, March 28, 2015: 9:55 AM

Salon C-D (Hilton Chicago)

L. M. Kuroki¹, K. Tatzel¹, M. A. Powell¹, D. G. Mutch¹, A. B. Dietz², W. Hawkins¹ and D. Spitzer¹
¹Washington University School of Medicine, St. Louis, MO, ²Mayo Clinic, Rochester, MN

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

332
Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death

332 Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death

332
Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death